Super Human Blend 865mg

No mechanism can be stated for this product, and the reason is not that the mechanism is complicated. It is that the composition is not disclosed. The listing describes the preparation as combining amino acid and cofactor constituents at 865mg per 10ml vial, which is 86.5mg per millilitre in total, and it names none of them.

That phrase is the only compositional information available. Amino acid and cofactor is a category spanning several hundred candidate compounds with unrelated actions, so it constrains almost nothing. A preparation of branched-chain amino acids and a preparation of glycine with a B vitamin would both satisfy the description while behaving entirely differently.

Every other record in this catalogue derives its mechanism from named constituents with published pharmacology. Where a blend is involved, as with GLOW or the Wolverine vial, the constituents are stated and the mechanism is the sum of what each is known to do. Here that chain cannot start. Writing a plausible mechanism from the product's category would mean inventing one, which is the failure mode this catalogue's research records exist to avoid.

This product's specification states a purity of greater than 99 percent by HPLC. Its own overview states that the preparation is characterised by composition rather than by a single molecular identity, and that no single CAS number, molecular formula or molecular weight applies. Both statements cannot be doing useful work at once.

Purity by HPLC is the proportion of chromatographic signal attributable to one intended substance. For a deliberate mixture of several intended substances the measure has no single referent: greater than 99 percent of what? If it means the sum of all intended constituents against everything else, it is informative and should say so. If it refers to one constituent measured alone, it says nothing about the others. If it is a field carried over from a single-compound template, it says nothing at all.

This is checkable and worth raising with any supplier of any blend. The overview is the more honest of the two statements, and it implies the purity line should be replaced by per-constituent identity and concentration rather than sitting alongside it.

The overview states that each lot ships with batch-specific composition and identity documentation, and describes that as the meaningful quality record for a blend in place of a single-compound purity figure. That is exactly the right principle, and it means a constituent list with concentrations exists somewhere.

It is simply not published. The gap here is between what the product says its documentation contains and what a reader can see before deciding to buy, and those are different things.

The practical step for anyone evaluating this preparation is to ask for that batch documentation before purchase rather than after, and to check that it names each constituent with a concentration rather than repeating the aggregate figure.

Every other product in this catalogue has a Research and Literature block built from published work on named compounds. This one cannot have that, and the alternative options were to leave the page empty or to write something that reads like evidence without being evidence.

The second option is what the surrounding market does with proprietary blends, and it is how the KLOW record on this catalogue came to carry eight citations to papers that do not exist. Writing plausible mechanism from a product category is the same error at an earlier stage.

So this record states what is known, which is a total concentration and a category, and what is not, which is everything else. That is less satisfying than a mechanism and considerably more useful than an invented one.

There is no approval for this preparation in any jurisdiction. Material supplied for research is for in-vitro laboratory use only.

This is supplied as a sterile solution rather than a lyophilised powder, stored refrigerated at 2 to 8 degrees Celsius and protected from light, and not frozen. Those conditions are stricter than the dry peptides elsewhere in this catalogue require, which is expected: a solution has no lyophilisation protecting it from hydrolysis.

Analytically, a mixture of amino acids and cofactors is an awkward target. Amino acids other than the aromatic ones absorb almost nothing in the ultraviolet, so a diode array detector will miss most of them, while many cofactors absorb strongly. Any credible characterisation would need either derivatisation or mass spectrometric detection, which is the point the multi-detector work cited here makes.